Home - Products - Others - Other Targets - Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)

Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)

CAS No. ———

Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)( ——— )

Catalog No. M41177 CAS No. ———

Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)
  • Note
    Research use only, not for human use.
  • Brief Description
    Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)
  • Description
    Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    ———
  • Formula Weight
    846.02
  • Molecular Formula
    C43H551N7O9S
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Acetyl-L-histidine...

    N-Acetyl-L-histidine monohydrate (NAH) also exhibits a strong phylogenetic component in that it is a major osmolyte in the brain and eye of teleost (bony) fish, amphibians and reptiles, but is present in much lower amounts in brain and other tissues of homeothermic (endothermic) vertebrates.

  • Methoxychlor

    Methoxychlor an organochlorine pesticide is thought to be an endocrine disrupter that affects Ca2? homeostasis and cell viability in different cell models.

  • BLU2864

    BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .